Medgend Icon

Ledgend of Medicine







discontinued


Nizoral A-d FDA Approved Drugs

EXTINA [KetoconazoleC26H28Cl2N4O4]
RX
-
2% (topical aerosol, foam)
Mylan Pharms IncJun 12, 2007
  • Topical treatment of seborrheic dermatitis in immunocompetent patients 12 years of age and older.
  • Treatment of seborrhea dermatitis in humans.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

KETOCONAZOLE [KetoconazoleC26H28Cl2N4O4]
RX
-
2% (topical cream)
200mg (oral tablet)
Fougera PharmsApr 28, 2004
Perrigo IsraelAug 25, 2011
Perrigo New YorkJan 7, 2004
TevaApr 25, 2000
TolmarApr 11, 2005
MylanDec 23, 1999
TaroJun 15, 1999
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

KETOZOLE [KetoconazoleC26H28Cl2N4O4]
RX
-
2% (topical cream)
TaroDec 18, 2002
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

NIZORAL [KetoconazoleC26H28Cl2N4O4]
RX
-
2% (topical shampoo)
Janssen PharmsAug 31, 1990
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

NIZORAL A-D [KetoconazoleC26H28Cl2N4O4]
OTC
-
1% (topical shampoo)
Johnson And JohnsonOct 10, 1997
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

XOLEGEL [KetoconazoleC26H28Cl2N4O4]
RX
-
2% (topical gel)
Aqua PharmsJul 28, 2006
  • Treatment of seborrhea dermatitis in humans.
efficacy
0.0  (0)
side effects
0.0  (0)
danger
0.0  (0)

UNK

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.